Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1039 | 957 | 1138 | 1028 | 1249 | 1641 |
Fund Return | 3.86% | -4.29% | 13.85% | 0.93% | 4.55% | 5.08% |
Place in category | 1812 | 2030 | 1836 | 1489 | 1237 | 661 |
% in Category | 86 | 95 | 89 | 80 | 81 | 72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DWS Funds Invest ZukunftsStrategie | 6.03B | 16.26 | 3.29 | 4.13 | ||
Deutsche Bank Best Allocation Balan | 3.15B | 13.26 | 3.80 | 4.00 | ||
DWS Funds Invest Vermogensstrategie | 3.18B | 17.02 | 3.95 | 4.05 | ||
DWS Vermogensmandat Dynamik | 2.22B | 15.66 | 1.53 | 4.01 | ||
Deutsche Invest I Top Dividend FC | 2.02B | 12.41 | 6.98 | 6.52 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund E Acc EUR | 20.66M | 16.23 | 5.74 | 4.83 | ||
European Growth Fund Y Acc EUR | 252.13M | 17.90 | 7.45 | 6.50 | ||
European Growth Fund Y DIST EUR | 64.5M | 17.95 | 7.47 | 6.51 | ||
European Growth Fund A DIST Eue | 6.57B | 17.06 | 6.55 | 5.62 | ||
European Growth Fund A Acc EUR | 159.75M | 17.05 | 6.54 | 5.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.48 | 718.70 | -0.77% | |
AstraZeneca | GB0009895292 | 5.37 | 10,872.0 | +1.10% | |
Novo Nordisk B | DK0062498333 | 5.09 | 623.6 | +0.66% | |
Iberdrola | ES0144580Y14 | 4.59 | 13.790 | +0.77% | |
Compass | GB00BD6K4575 | 3.89 | 2,717.49 | +2.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review